EMEIS SA (EMEIS.PA) Stock Fundamental Analysis
Europe - EPA:EMEIS - FR001400NLM4 - Common Stock
14.31 EUR
-0.27 (-1.85%)
We assign a fundamental rating of 1 out of 10 to EMEIS. EMEIS was compared to 27 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of EMEIS have multiple concerns. EMEIS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
EMEIS had negative earnings in the past year.
EMEIS had a positive operating cash flow in the past year.
In multiple years EMEIS reported negative net income over the last 5 years.
Each year in the past 5 years EMEIS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EMEIS (-3.07%) is worse than 85.19% of its industry peers.
EMEIS has a worse Return On Equity (-23.89%) than 85.19% of its industry peers.
The Return On Invested Capital of EMEIS (0.03%) is worse than 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROIC | 0.03% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of EMEIS (0.08%) is worse than 85.19% of its industry peers.
EMEIS's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for EMEIS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
EMEIS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for EMEIS has been increased compared to 1 year ago.
EMEIS has less shares outstanding than it did 5 years ago.
EMEIS has a worse debt/assets ratio than last year.
2.2 Solvency
EMEIS has an Altman-Z score of 0.63. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EMEIS (0.63) is worse than 74.07% of its industry peers.
EMEIS has a debt to FCF ratio of 51.23. This is a negative value and a sign of low solvency as EMEIS would need 51.23 years to pay back of all of its debts.
The Debt to FCF ratio of EMEIS (51.23) is worse than 74.07% of its industry peers.
A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.
EMEIS has a worse Debt to Equity ratio (4.80) than 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.01
WACC4.62%
2.3 Liquidity
A Current Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.
EMEIS has a worse Current ratio (0.62) than 77.78% of its industry peers.
EMEIS has a Quick Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.
EMEIS's Quick ratio of 0.62 is on the low side compared to the rest of the industry. EMEIS is outperformed by 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
The earnings per share for EMEIS have decreased strongly by -136.53% in the last year.
Looking at the last year, EMEIS shows a small growth in Revenue. The Revenue has grown by 6.30% in the last year.
The Revenue has been growing by 8.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
3.2 Future
The Earnings Per Share is expected to grow by 17.92% on average over the next years. This is quite good.
Based on estimates for the next years, EMEIS will show a small growth in Revenue. The Revenue will grow by 2.70% on average per year.
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EMEIS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
EMEIS's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. EMEIS is more expensive than 85.19% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as EMEIS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.24 | ||
| EV/EBITDA | 22.55 |
4.3 Compensation for Growth
EMEIS's earnings are expected to grow with 21.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.28%
EPS Next 3Y21.78%
5. Dividend
5.1 Amount
No dividends for EMEIS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:EMEIS (10/31/2025, 7:00:00 PM)
14.31
-0.27 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners56.3%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap2.31B
Revenue(TTM)5.77B
Net Income(TTM)-412065000
Analysts75.38
Price Target13.46 (-5.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-98.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.41 | ||
| P/FCF | 13.24 | ||
| P/OCF | 4.89 | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.55 |
EPS(TTM)-1.8
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)1.08
FCFY7.55%
OCF(TTM)2.92
OCFY20.43%
SpS34.91
BVpS10.68
TBVpS-7.69
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.07% | ||
| ROE | -23.89% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.08% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 3.1% |
ROA(3y)-7.04%
ROA(5y)-3.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-77.23%
ROICexgc growth 5Y-61.49%
ROICexc growth 3Y-76.08%
ROICexc growth 5Y-60.94%
OM growth 3Y-79.31%
OM growth 5Y-64.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.8 | ||
| Debt/FCF | 51.23 | ||
| Debt/EBITDA | 17.9 | ||
| Cap/Depr | 64.95% | ||
| Cap/Sales | 5.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.08% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.62 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 0.63 |
F-Score4
WACC4.62%
ROIC/WACC0.01
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.82%
Cap/Sales(5y)13.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.96%
EPS Next Y24.08%
EPS Next 2Y24.28%
EPS Next 3Y21.78%
EPS Next 5Y17.92%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y9.45%
Revenue growth 5Y8.55%
Sales Q2Q%4.92%
Revenue Next Year4.84%
Revenue Next 2Y4.72%
Revenue Next 3Y4.75%
Revenue Next 5Y2.7%
EBIT growth 1Y103.51%
EBIT growth 3Y-77.35%
EBIT growth 5Y-61.53%
EBIT Next Year10732.9%
EBIT Next 3Y416.71%
EBIT Next 5Y253.09%
FCF growth 1Y293.3%
FCF growth 3YN/A
FCF growth 5Y14.58%
OCF growth 1Y28.92%
OCF growth 3Y-14.44%
OCF growth 5Y-10.16%
EMEIS SA / EMEIS.PA FAQ
What is the ChartMill fundamental rating of EMEIS SA (EMEIS.PA) stock?
ChartMill assigns a fundamental rating of 1 / 10 to EMEIS.PA.
What is the valuation status for EMEIS stock?
ChartMill assigns a valuation rating of 1 / 10 to EMEIS SA (EMEIS.PA). This can be considered as Overvalued.
What is the profitability of EMEIS stock?
EMEIS SA (EMEIS.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for EMEIS stock?
The financial health rating of EMEIS SA (EMEIS.PA) is 0 / 10.
Can you provide the dividend sustainability for EMEIS stock?
The dividend rating of EMEIS SA (EMEIS.PA) is 0 / 10 and the dividend payout ratio is 0%.